2020年

1. Zhong C, Kayamori K, Koide S, Shinoda D, Oshima M, Nakajima-Takagi Y, Nagai Y, Mimura N, Sakaida E, Yamazaki S, Iwano S, Miyawaki A, Ito R, Tohyama K, Yamaguchi K, Furukawa Y, Lennox W, Sheedy J, Weetall M, Iwama A. Efficacy of the novel tubulin polymerization inhibitor PTC-028 for myelodysplastic syndrome. Cancer Sci, 111(12):4336-4347, 2020.
2. Omori S, Wang TW, Johmura Y, Kanai T, Nakano Y, Kido T, Susaki EA, Nakajima T, Shichino S, Ueha S, Ozawa M, Yokote K, Kumamoto S, Nishiyama A, Sakamoto T, Yamaguchi K, Hatakeyama S, Shimizu E, Katayama K, Yamada Y, Yamazaki S, Iwasaki K, Miyoshi C, Funato H, Yanagisawa M, Ueno H, Imoto S, Furukawa Y, Yoshida N, Matsushima K, Ueda HR, Miyajima A, Nakanishi M. Generation of a p16 reporter mouse and its use to characterize and target p16high cells in vivo. Cell Metab, 32(5):814-828.e6, 2020.
3. Jinawath N, Shiao MS, Chanpanitkitchote P, Svasti J, Furukawa Y, Nakamura Y. Enhancement of migration and invasion of gastric cancer cells by IQGAP3. Biomolecules, 10(8):E1194, 2020.
4. Fujimoto K, Kimura Y, Shimohigoshi M, Satoh T, Sato S, Tremmel G, Uematsu M, Kawaguchi Y, Usui Y, Nakano Y, Hayashi T, Kashima K, Yuki Y, Yamaguchi K, Furukawa Y, Kakuta M, Akiyama Y, Yamaguchi R, Crowe SE, Ernst PB, Miyano S, Kiyono H, Imoto S, Uematsu S. Metagenome data on intestinal phage–bacteria associations aids the development of phage therapy against pathobionts. Cell Host & Microbe, 28(3):380-389.e9, 2020.
5. Yoshino S, Matsui Y, Fukui Y, Seki M, Yamaguchi K, Kanamori A, Saitoh Y, Shimamura T, SuzukibY, Furukawa Y, Kaneko S, Seiki M, Murakami Y, Inoue J, Sakamoto T. EXOSC9 depletion attenuates P-body formation, stress resistance, and 1 tumorigenicity of cancer cells. Sci Rep, 10(1):9275, 2020.
6. Yamaguchi K, Nagatoishi S, Tsumoto K, Furukawa Y. Discovery of chemical probes that suppress Wnt/β-catenin signaling through high-throughput screening. (Review) Cancer Sci, 111(3):783-794, 2020.